SHORT ANSWER
Stripe's public list never uses the word “peptide.” It prohibits “incorrectly labeled research chemicals” and pseudo-pharmaceuticals that “make harmful claims,” and its FAQ says research peptides may be sold “as long as there are preventive measures in place.” Every account is reviewed individually, approval is specific to each service, and Stripe can modify or revoke it at any time.
This material is general educational information as of the “last reviewed” date. It is not legal advice and may not reflect later developments or facts specific to your business. Links are provided so readers can inspect the primary or official sources.
01 / WHAT IT IS
A private contractual rule, not a law
Stripe's Prohibited and Restricted Businesses page is part of the terms a merchant agrees to when opening an account. It is Stripe's own rule, shaped by what the page calls “rules and policies set by our financial partners, such as card networks and banking partners,” and by Stripe's legal obligations as a financial services company.
That framing matters for how to read it. A statute applies to everyone the same way. A private policy applies to the account in front of the reviewer, on the day of review, under whatever version of the page is current. The page carries a “Last updated” stamp, which read 2026-05-13 when this guide was written, and the FAQ describes the categories as “representative but not exhaustive.”
Quotations in this guide come from the two Stripe pages as they read on September 3, 2026. Stripe changes them. Check the live pages before relying on any line here.
02 / THE CATEGORIES
The lines that reach a peptide storefront
The word “peptide” does not appear on the restricted businesses page itself. Three listed items reach the category anyway, and a reviewer reads a storefront against all of them.
- Under prohibited “Illegal weapons, explosives, and dangerous materials”: “Incorrectly labeled research chemicals.” The operative word is labeled. A product presented as a research chemical whose surrounding copy points to another use is, in Stripe's framing, incorrectly labeled.
- Under prohibited “Nutraceuticals and pseudo-pharmaceuticals”: products “that are not safe or make harmful claims.” Health-outcome language on a product page is what turns a listing into a pseudo-pharmaceutical making claims.
- Under restricted “Pharmaceuticals, medical devices, and telemedicine”: “card-not-present prescription-only products and pharmaceuticals.” Compounds that are prescription-only in the United States, sold online, fall here regardless of what the label says.
03 / PROHIBITED VS RESTRICTED
Two lists with different consequences
Stripe's page separates prohibited businesses, which it describes as businesses that “can't use Stripe,” from restricted businesses, described as “industries and products that require additional due diligence.” The FAQ adds that Stripe “might be able to support” some listed businesses “with explicit prior approval,” while “certain categories, including illegal products or services, are never eligible.”
For a peptide storefront the practical reading is this: the research-chemical and pseudo-pharmaceutical lines are on the prohibited side, and whether a given store lands there depends on labeling and claims. The pharmaceutical line is on the restricted side, where Stripe says it will ask for “additional information (such as proof of relevant licenses or more details about your business model).”
04 / THE FAQ LINE
Where Stripe addresses research peptides directly
Stripe's support FAQ is the only place either page names peptides. It states that peptides for research purposes may be sold on Stripe “as long as there are preventive measures in place” to keep them from buyers who would purchase research chemicals for nonresearch purposes.
Three things about that sentence are worth noticing. It conditions eligibility on measures, not on a disclaimer. It describes the measures by their purpose, keeping products away from nonresearch buyers, rather than by a checklist. And it sits in a support article, which Stripe can edit without the “Last updated” stamp the main policy carries.
05 / PREVENTIVE MEASURES
What the condition asks of a storefront
Stripe does not publish a list of acceptable measures. Read against the purpose it states, the measures a reviewer can observe on a public storefront fall into two groups.
- Buyer controls: attestation of research use at checkout, institutional or business-purchaser gating, quantity limits, and refusal of orders that name a person as the end user.
- Presentation controls: product names, descriptions, imagery, and bundled supplies that do not describe effects in people or supply a route of administration. A control that gates the checkout while the product page describes weight loss contradicts itself.
- Consistency across the whole site: blog posts, reviews, social links, and metatags that point to human use undercut a gate on the cart page.
Putting measures in place makes a storefront easier to review against the FAQ's condition. It does not obligate Stripe to approve the account, and RUO Clear never represents that it does.
06 / ACCOUNT REVIEW
Every account is reviewed on its own facts
The FAQ states that Stripe independently reviews every account and all relevant information during activation, and that this review determines whether a business is supported. The policy page adds that any approval “is specific to each service offer” and “may be modified or revoked by Stripe at any time.”
Read together, the two pages describe a process rather than a rule: a category-level screen, a document request for restricted categories, an individual decision, and a standing right to change it. A storefront that passed review last year is reviewed again against the page as it reads today.
07 / WHAT IT DOES NOT PREDICT
The limits of reading the policy
A careful reading of Stripe's pages tells a merchant what will be looked at. It does not tell them the outcome. Nothing in the policy commits Stripe to approve a storefront that meets the FAQ's condition, to keep an approved account open, to set any particular reserve, or to give notice before a change.
That is why this guide describes what a storefront can make observable, and stops there. Review the presentation against the three category lines above, put buyer controls in place that serve the stated purpose, and keep a record of what was changed and when. What a provider decides with that record is the provider's decision.
QUESTIONS
Related questions
Does Stripe ban peptides outright?
The word does not appear on the main list. The prohibited lines that reach peptides are about labeling and claims, and the FAQ says research peptides may be sold with preventive measures in place. Whether a specific store is supported is decided in Stripe's individual account review.
Is a research-use-only disclaimer a preventive measure?
Stripe's FAQ describes measures by their purpose: keeping products away from nonresearch buyers. A disclaimer states a boundary; it does not enforce one. Checkout gating, purchaser attestation, and consistent product presentation are the observable measures that serve the stated purpose.
If my store meets the FAQ's condition, will Stripe approve it?
Stripe's pages do not say that, and neither does RUO Clear. Approval is specific to each account and service, follows an individual review, and can be modified or revoked. Meeting the condition makes a storefront reviewable; it does not decide the review.
Why does the policy cite card networks and banking partners?
Stripe states that its list reflects rules and policies set by its financial partners as well as its own obligations. That is one reason categories can change without a change in law, and why the same storefront can be treated differently by different processors.
SOURCES
Sources cited
Each source is listed with its class so government authority, agency guidance, enforcement examples, and private policy are never blended into one rule.
The category list. Quoted lines: “incorrectly labeled research chemicals,” pseudo-pharmaceuticals that “make harmful claims,” card-not-present prescription-only products, and the approval and revocation language.
The only Stripe page that names peptides. States the preventive-measures condition, individual account review, and that the list is representative, not exhaustive.
The FDA framework behind “incorrectly labeled”: intended use is read from labeling, advertising, and circumstances of distribution, not from the label alone.